analyst
RA
NASDAQ · RARE
Ultragenyx Pharmaceutical Inc.
Healthcare · Biotechnology
$25.21
Down-$0.40 (-1.56%)
Updated Sep 1, 2026, 6:33 AM
SID Score
4.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.49B
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $18.29 – $39.89
- Volume
- 1.93M
- Avg. volume
- 1.5M
Price performance
RARE price history
1M range · 21 trading sessions · Daily adjusted prices
RARE closed at $25.21 after 21 trading sessions, up 0.76% for the selected period.
- Last close
- $25.21
- Period change
- +0.76%
- Period low
- $24.93
- Period high
- $26.96
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $25.45 | $25.90 | $24.7308 | $25.21 | 1.93M |
| Aug 28, 2026 | $26.54 | $26.73 | $25.37 | $25.61 | 1.61M |
| Aug 27, 2026 | $26.38 | $26.56 | $25.83 | $26.26 | 1.14M |
| Aug 26, 2026 | $26.545 | $26.665 | $25.6132 | $26.44 | 1.67M |
| Aug 25, 2026 | $26.25 | $26.915 | $26.00 | $26.46 | 3.81M |
| Aug 24, 2026 | $25.75 | $26.0899 | $25.30 | $25.72 | 1.54M |
| Aug 21, 2026 | $25.76 | $26.75 | $25.69 | $25.83 | 2.4M |
| Aug 20, 2026 | $28.39 | $28.50 | $25.04 | $25.32 | 3.84M |
| Aug 19, 2026 | $26.28 | $26.68 | $26.00 | $26.24 | 2.85M |
| Aug 18, 2026 | $25.68 | $26.1085 | $24.97 | $25.49 | 1.79M |
| Aug 17, 2026 | $26.26 | $26.5099 | $25.81 | $26.13 | 1.32M |
| Aug 14, 2026 | $26.30 | $26.58 | $25.75 | $26.49 | 1.22M |
| Aug 13, 2026 | $27.07 | $27.17 | $26.33 | $26.38 | 946.13K |
| Aug 12, 2026 | $26.79 | $27.16 | $26.11 | $26.86 | 1.55M |
| Aug 11, 2026 | $27.16 | $27.5869 | $26.42 | $26.96 | 2.14M |
| Aug 10, 2026 | $25.91 | $27.11 | $25.51 | $26.80 | 2.36M |
| Aug 7, 2026 | $26.34 | $26.71 | $25.30 | $25.91 | 3.83M |
| Aug 6, 2026 | $24.99 | $26.10 | $24.805 | $25.82 | 1.96M |
| Aug 5, 2026 | $28.48 | $28.48 | $24.605 | $24.93 | 2.64M |
| Aug 4, 2026 | $25.19 | $26.13 | $25.005 | $25.81 | 2.1M |
| Aug 3, 2026 | $24.92 | $25.40 | $24.01 | $25.02 | 2.09M |
Latest RARE news
The latest Smart Investors Daily articles mentioning RARE.
Stock researchResearch & News · SEC Filings
Loading stock research…